Ipilimumab and Nivolumab in Leptomeningeal Metastases From Melanoma
Conditions: Leptomeningeal Carcinomatosis; Melanoma Interventions: Drug: Nivolumab; Drug: Ipilimumab Sponsors: Massachusetts General Hospital; Bristol-Myers Squibb Not yet recruiting - verified September 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Hospitals | Melanoma | Neoplastic Meningitis | Skin Cancer | Yervoy